A possible second mechanism to explain our findings is that, like S100A8/A9, other factors that are present during arthritis development can induce IL-1β expression and regulate its activation and as such be sufficient to fully activate IL-1β in Il1rn−/−XS100a9−/− mice [38–41]. The gene discussed is IGKV1D-22; the disease is arthritic joint disease.